Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair

Brett A. Shook(Yale University), Renee R. Wasko(Yale University), Guillermo C. Rivera-Gonzalez(Yale University), Emilio Salazar-Gatzimas(Yale University), Francesc López‐Giráldez, Biraja C. Dash(Yale University), Andrés Rojas(Yale University), Krystal D. Aultman(Yale University), Rachel K. Zwick(Yale University), Vivian Lei(Yale University), Jack L. Arbiser(Emory University), Kathryn Miller‐Jensen(Yale University), Damon A. Clark(Yale University), Henry C. Hsia(Yale University), Valerie Horsley(Yale University)
Science
November 22, 2018
Cited by 507Open Access
Full Text

Abstract

During tissue repair, myofibroblasts produce extracellular matrix (ECM) molecules for tissue resilience and strength. Altered ECM deposition can lead to tissue dysfunction and disease. Identification of distinct myofibroblast subsets is necessary to develop treatments for these disorders. We analyzed profibrotic cells during mouse skin wound healing, fibrosis, and aging and identified distinct subpopulations of myofibroblasts, including adipocyte precursors (APs). Multiple mouse models and transplantation assays demonstrate that proliferation of APs but not other myofibroblasts is activated by CD301b-expressing macrophages through insulin-like growth factor 1 and platelet-derived growth factor C. With age, wound bed APs and differential gene expression between myofibroblast subsets are reduced. Our findings identify multiple fibrotic cell populations and suggest that the environment dictates functional myofibroblast heterogeneity, which is driven by fibroblast-immune interactions after wounding.


Related Papers

No related papers found

Powered by citation graph analysis